1. INTRODUCTION

The current interest in nanotechnology and its application to the medical field has historical precedent. Initial products employed general physical chemistry of colloids to produce stable drug suspensions and improve bioavailability. The later introduction of liposomes began the evolution to today’s more sophisticated and potentially revolutionary new technologies, which have accompanied the rapid growth in biotechnology product opportunities, notably including targeted drug delivery products.